pr-inside.com
Print
ImClone Systems Incorporated - SWOT Analysis

ImClone Systems Incorporated - SWOT Analysis - www.companiesandmarkets.com adds new report



2008-07-18 07:25:16 - ImClone Systems Incorporated - SWOT Analysis - a new market research report on www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/ImClone-Syst ..

ImClone Systems Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

ImClone Systems (ImClone) is a biopharmaceutical company specializing in the development of therapeutic products for the treatment

 

 

of cancer and cancer-related disorders, as well as diagnostic products and vaccines for a number of infectious diseases. ImClone is headquartered in New York City, New York and employs about 1,000 people. The company recorded revenues of $590.8 million during the fiscal year ended December 2007, a decrease of 12.8% over 2006. The operating profit of the company was $51.5 million during fiscal year 2007, compared to an operating profit of $289.2 million in 2006. The net profit in fiscal year 2007 was $39.8 million, compared to a net profit of $370.7 million in 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

www.companiesandmarkets.com/Summary-Company-Profile/ImClone-Syst ..

Author:
Mike King
e-mail
Web: http://www.companiesandmarkets.com
Telefon: London: +44 (0) 203 086 8600




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.